Serum Chromogranin-A based Prognosis In Metastatic Castration Resistant Prostate Cancer

OBJECTIVE: To determine the prognostic value of serum chromogranin-A (CGA) in a two-cohort study of men with metastatic castrate resistant prostate cancer (mCRPC) and to compare with circulating tumor cells (CTCs) based prognosis. PATIENTS AND METHODS: A two cohort based evaluation for serum CGA for...

Descripción completa

Detalles Bibliográficos
Autores principales: Giridhar, Karthik V., Sanhueza, Cristobal, Hillman, David, Alkhateeb, Hassan, Carlson, Rachel, Tan, Winston, Costello, Brian A., Quevedo, Fernando, Pagliaro, Lance, Kohli, Manish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126956/
https://www.ncbi.nlm.nih.gov/pubmed/29858590
http://dx.doi.org/10.1038/s41391-018-0046-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126956/
https://www.ncbi.nlm.nih.gov/pubmed/29858590
http://dx.doi.org/10.1038/s41391-018-0046-9

Ejemplares similares